Obstetrics, gynecology, andrology, sexual and reproductive health

Menopause

Guidelines, reviews, epidemiology

 

Menopause, hormone replacement therapy

• Asia
  • Climacteric
    • Updated clinical recommendations for the use of tibolone in Asian women [2010]
• Australia
  • Australian Journal of General Practice
    • Making choices at menopause [2019]
  • BMC Women's Health
    • Menopause and the influence of culture: another gap for Indigenous Australian women? [2012]
• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Managing menopausal symptoms [2020]
• Austria, Germany
  • Geburtshilfe und Frauenheilkunde
    • Perimenopause and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020) [2021]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Oral Progesterone for the Treatment of Menopausal Symptoms: A Review of the Clinical Evidence [2014]
  • Society of Obstetricians and Gynaecologists of Canada
    • Managing Menopause Chapter 7 Ongoing Management of Menopausal Women and Those With Special Considerations [2014]
    • Managing Menopause Chapter 6 Prescription Therapeutic Agents [2014]
    • Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women [2014]
    • Managing Menopause Abstract and Summary Statement [2014]
• Canada, United States
  • North American Menopause Society
    • The 2022 hormone therapy position statement of The North American Menopause Society [2022]
    • Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling [2020]
    • Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois [2020]
    • The 2017 hormone therapy position statement of The North American Menopause Society [2017]
    • Scientific Background Report for the 2017 Hormone Therapy Position Statement of The North American Menopause Society [2017]
    • The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65 [2015]
    • NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older [2015]
    • Why the product labeling for low-dose vaginal estrogen should be changed [2014]
    • The North American Menopause Society Recommendations for Clinical Care of Midlife Women [2014]
    • Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society [2014]
• China
  • Menopause
    • Prevalence and risk factors for menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study [2021]
• Europe
  • European Menopause and Andropause Society
    • Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement [2021]
    • A model of care for healthy menopause and ageing: EMAS position statement [2016]
    • EMAS position statement: The ten point guide to the integral management of menopausal health [2015]
  • European Society of Human Reproduction and Embryology
    • Perimenopausal risk factors and future health [2011]
• France
  • Maturitas
    • Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines [2022]
• Germany
  • Archives of Gynecology and Obstetrics
    • Peri- and postmenopause—diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015/062): short version [2020]
    • Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version [2011]
  • Deutsches Ärzteblatt International
    • The Treatment of Climacteric Symptoms [2012]
• India
  • Journal of Mid-Life Health
    • Clinical Practice Guidelines on Menopause and Postmenopausal Osteoporosis [2020]
• International
  • Climacteric
    • Global Consensus Statement on Menopausal Hormone Therapy [2013]
  • European Menopause and Andropause Society
    • European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis [2020]
  • Fertility and Sterility
    • Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging [2012]
  • PLoS Medicine
    • Menopausal hormone therapy and women’s health: An umbrella review [2021]
    • Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies [2018]
  • Reproductive Health
    • A review of menopause nomenclature [2022]
• Israel
  • International Journal of Women's Health
    • Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis [2020]
• Italy
  • BMC Women's Health
    • Informing women about hormone replacement therapy: the Consensus conference statement [2009]
• Japan
  • Journal of Epidemiology
    • Prevalence of the Use of Oral Contraceptives and Hormone Replacement Therapy in Japan: The Japan Nurses' Health Study [2022]
• Norway
  • Human Reproduction
    • Temporal trends in age at menarche and age at menopause: a population study of 312 656 women in Norway [2020]
• Poland
  • Ginekologia Polska
    • Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women — position statement of expert panel of Polish Menopause and Andropause Society [2020]
  • Przeglad Menopauzalny = Menopause Review
    • Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg [2021]
    • Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society – state of knowledge as of December 2013 [2014]
• Republic of Korea
  • Journal of Menopausal Medicine
    • The 2020 Menopausal Hormone Therapy Guidelines [2020]
  • Lancet Regional Health: Western Pacific
    • Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western women [2021]
  • Scientific Reports
    • The beneficial effects of menopausal hormone therapy on renal survival in postmenopausal Korean women from a nationwide health survey [2021]
• Republic of Korea, United States
  • Journal of Korean Medical Science
    • Trends of Premature and Early Menopause: a Comparative Study of the US National Health and Nutrition Examination Survey and the Korea National Health and Nutrition Examination Survey [2020]
• United Kingdom
  • British Menopause Society
    • Developing the Women's health strategy: The British Menopause Society's recommendations to the department of health and social care's call for evidence [2022]
    • Joint BMS / FSRH / RCGP / RCOG framework for restoration of menopause services in response to COVID-19 [2020]
  • Journal of Virus Eradication
    • Menopause care in women living with HIV in the UK - A review [2022]
  • National Institute for Health and Care Excellence
    • Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause [2022]
    • Menopause: diagnosis and management [2019]
    • Menopause (Quality standard) [2017]
    • Menopause
  • Post Reproductive Health
    • An online survey and interview of GPs in the UK for assessing their satisfaction regarding the medical training curriculum and NICE guidelines for the management of menopause [2022]
  • Royal College of Obstetricians and Gynaecologists
    • Ovarian Cysts in Postmenopausal Women [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force [2022]
    • Menopausal Symptoms: Comparative Effectiveness of Therapies [2015]
    • Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions [2012]
  • American Association of Clinical Endocrinologists
    • American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update [2017]
  • American College of Obstetricians and Gynecologists
    • Compounded Bioidentical Menopausal Hormone Therapy [2012]
  • American Society for Reproductive Medicine
    • Menopause
  • Climacteric
    • Physiologic and psychosocial changes of the menopause transition in US Latinas: A narrative review [2021]
  • Endocrine Society
    • Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline [2015]
    • Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement [2010]
  • Frontiers in Endocrinology
    • Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts [2021]
  • JAMA
    • Trends in Age at Natural Menopause and Reproductive Life Span Among US Women, 1959-2018 [2021]
  • Menopause
    • Menopausal Hormone Therapy Trends Before Versus After 2002: Impact of the Women’s Health Initiative Study Results [2018]
  • National Cancer Institute
    • Menopausal Hormone Therapy and Cancer
  • Obstetrics & Gynecology Clinics of North America
    • The SWAN Song: Study of Women’s Health Across the Nation’s Recurring Themes [2011]
    • Reproductive Hormones and the Menopause Transition [2011]
    • Physical Activity and Health During the Menopausal Transition [2011]
    • Menstruation and the Menopause Transition [2011]
    • Adrenal Androgens and the Menopausal Transition [2011]
  • Society for Women's Health Research
    • Menopause preparedness: perspectives for patient, provider, and policymaker consideration [2021]
  • Society of Gynecologic Oncology
    • Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement [2020]
  • U.S. Pharmacist
    • Hormone Replacement Therapy for Menopausal Symptoms [2018]
  • U.S. Preventive Services Task Force
    • Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions [2022]
• WHO
  • World Health Organization
    • Menopause: Fact sheet
• {Related topics}
  • Guidelines
    • Osteoporosis
    • Menopause: alternative therapy
    • Menopause, hormone replacement therapy: hot flashes, vasomotor symptoms
    • Menopause, hormone replacement therapy: genitourinary syndrome, sexual disorders
    • Menopause, hormone replacement therapy: abnormal bleeding
    • Menopause, hormone replacement therapy, mental disorders
    • Menopause, hormone replacement therapy, cardiovascular disease
    • Menopause, hormone replacement therapy, breast cancer

Menopause, hormone replacement therapy, breast cancer

• Australia
  • Cancer Australia
    • Management of menopausal symptoms in women with a history of breast cancer [2016]
    • Hormone replacement therapy and risk of breast cancer [2010]
• Canada
  • Journal of the National Cancer Institute
    • Breast Cancer Incidence and Hormone Replacement Therapy in Canada [2010]
  • Society of Obstetricians and Gynaecologists of Canada
    • Menopause and Breast Cancer [2021]
    • Managing Menopause Chapter 3 Menopausal Hormone Therapy and Breast Cancer [2014]
• Denmark
  • Cancer Causes and Control
    • Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study [2018]
• India
  • Journal of Mid-Life Health
    • Menopause Hormone Therapy in the Changing Trends of Breast Cancer in India [2020]
• International
  • Breast Cancer Research and Treatment
    • Hormone replacement therapy and mammographic density: a systematic literature review [2020]
  • Evidence-based Complementary and Alternative Medicine
    • Nonhormonal Hot Flash Management for Breast Cancer Survivors: A Systematic Review and Network Meta-Analysis [2020]
  • Lancet
    • Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence [2019]
• Israel
  • International Journal of Women's Health
    • Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study [2021]
• Norway
  • Cancer Medicine
    • Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study [2015]
• Republic of Korea
  • Cancer Epidemiology Biomarkers & Prevention
    • Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort [2020]
  • Journal of Preventive Medicine and Public Health
    • Hormone Replacement Therapy and Risk of Breast Cancer in Korean Women: A Quantitative Systematic Review [2015]
• Taiwan
  • International Journal of Environmental Research and Public Health
    • The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan [2016]
• United Kingdom
  • BMJ
    • Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases [2020]
  • British Menopause Society
    • British Menopause Society consensus statement: The risks and benefits of HRT before and after a breast cancer diagnosis [2019]
    • British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer [2019]
    • The diagnosis of the menopause and management of oestrogen deficiency symptoms and arthralgia in women treated for breast cancer [2018]
  • Medicines and Healthcare products Regulatory Agency
    • Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping [2019]
• United States
  • American College of Obstetricians and Gynecologists
    • Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer [2021]
  • Breast Cancer Research
    • Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort [2020]
  • Cancer
    • Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women [2020]
  • JAMA
    • Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials [2020]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy
    • Breast cancer

Menopause, hormone replacement therapy, cardiovascular disease

• Australia, Europe
  • Human Reproduction
    • Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies [2020]
• Australia, United Kingdom, United States
  • American Journal of Obstetrics & Gynecology
    • Vasomotor Menopausal Symptoms and Risk of Cardiovascular Disease: A pooled analysis of six prospective studies [2020]
• Canada
  • Menopause
    • Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging [2021]
  • Society of Obstetricians and Gynaecologists of Canada
    • Menopause and Cardiovascular Disease [2021]
    • Managing Menopause Chapter 2 Cardiovascular Disease [2014]
• Europe
  • European Heart Journal
    • Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists [2007]
  • European Society of Cardiology
    • Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists [2021]
  • International Journal of Epidemiology
    • Association of menopausal characteristics and risk of coronary heart disease: a pan-European case–cohort analysis [2019]
• High-income countries
  • Lancet Public Health
    • Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data [2019]
• International
  • BioMed Research International
    • Meta-analysis: Early Age at Natural Menopause and Risk for All-Cause and Cardiovascular Mortality [2021]
  • Scientific Reports
    • A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases [2020]
• Netherlands
  • Stroke
    • Age at Menopause and Risk of Ischemic and Hemorrhagic Stroke [2021]
• Republic of Korea
  • Asian Nursing Research
    • Incidence and Risk Factors of Cardio-Cerebrovascular Disease in Korean Menopausal Women: A Retrospective Observational Study using the Korean Genome and Epidemiology Study data [2021]
• Spain
  • Maturitas
    • Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia [2020]
• Sweden
  • PLoS Medicine
    • Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies [2017]
• Taiwan
  • ESC Heart Failure
    • Menopausal symptoms and risk of heart failure: a retrospective analysis from Taiwan National Health Insurance Database [2021]
  • PLoS ONE
    • Menopausal symptoms and risk of coronary heart disease in middle-aged women: A nationwide population-based cohort study [2018]
• United Kingdom
  • BMJ
    • Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases [2019]
  • JAMA
    • Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease [2019]
• United States
  • American College of Obstetricians and Gynecologists
    • Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism [2013]
    • Hormone Therapy and Heart Disease [2013]
  • American Heart Association
    • Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association [2020]
    • Guidelines for the Prevention of Stroke in Women [2014]
    • Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update [2011]
    • Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee [2006]
    • Women’s Ischemic Syndrome Evaluation: Section 4: Lessons From Hormone Replacement Trials [2004]
  • Cleveland Clinic Journal of Medicine
    • Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk [2022]
  • Journal of the American Heart Association
    • Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN [2021]
    • Cardiovascular Disease Risk Factor Burden During the Menopause Transition and Late Midlife Subclinical Vascular Disease: Does Race/Ethnicity Matter? [2020]
  • Therapeutic Advances in Endocrinology and Metabolism
    • Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use [2021]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy

Menopause, hormone replacement therapy, mental disorders

• Canada
  • Society of Obstetricians and Gynaecologists of Canada
    • Menopause: Mood, Sleep, and Cognition [2021]
• Canada, United States
  • North American Menopause Society
    • Guidelines for the Evaluation and Treatment of Perimenopausal Depression [2018]
• Finland
  • Neurology
    • Postmenopausal hormone therapy and Alzheimer disease [2017]
• International
  • World Journal of Psychiatry
    • Menopause and cognitive impairment: A narrative review of current knowledge [2021]
• Singapore
  • American Journal of Obstetrics & Gynecology
    • Reproductive and hormonal factors and risk of cognitive impairment among Singapore Chinese women [2020]
• United Kingdom
  • BMJ
    • Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases [2021]
• United States
  • Agency for Healthcare Research and Quality
    • Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia [2017]
  • Obstetrics & Gynecology Clinics of North America
    • Sleep During the Perimenopause: A SWAN Story [2011]
    • Perimenopause and Cognition [2011]
    • Mood and Menopause: Findings from the Study of Women’s Health Across the Nation (SWAN) over ten years [2011]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy

Menopause, hormone replacement therapy: abnormal bleeding

• Hong Kong
  • Hong Kong College of Obstetricians and Gynaecologists
    • Guideline on investigations of premenopausal women with abnormal uterine bleeding [2020]
• Ireland
  • Ireland's Health Services
    • Assessment and Management of Postmenopausal Bleeding [2022]
• United States
  • American College of Obstetricians and Gynecologists
    • The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding [2018]
  • Permanente Journal
    • Investigation of Women with Postmenopausal Uterine Bleeding: Clinical Practice Recommendations [2014]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy

Menopause, hormone replacement therapy: genitourinary syndrome, sexual disorders

• Canada
  • Society of Obstetricians and Gynaecologists of Canada
    • Menopause and Sexuality [2021]
    • Menopause and Genitourinary Health [2021]
    • Managing Menopause Chapter 8 Sexuality and Menopause [2014]
    • Managing Menopause Chapter 5 Urogenital Health [2014]
• Canada, United States
  • North American Menopause Society
    • The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society [2020]
    • Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health [2018]
    • Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society [2014]
    • Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society [2013]
• Europe
  • Acta Obstetricia et Gynecologica Scandinavica
    • The role of testosterone in menopausal hormone treatment. What is the evidence? [2020]
  • European Menopause and Andropause Society
    • Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide [2021]
• International
  • Clinical Endocrinology
    • A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women [2019]
  • Frontiers in Medicine
    • Prevalence of Psychosomatic and Genitourinary Syndrome Among Menopausal Women: A Systematic Review and Meta-Analysis [2022]
  • International Journal of Environmental Research and Public Health
    • Effects of Physical Exercise on Sexual Function and Quality of Sexual Life Related to Menopausal Symptoms in Peri- and Postmenopausal Women: A Systematic Review [2020]
  • International Society for the Study of Women’s Sexual Health
    • International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women [2021]
  • Journal of Clinical Endocrinology & Metabolism
    • Global Consensus Position Statement on the Use of Testosterone Therapy for Women [2019]
  • Menopause
    • Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review [2019]
• Italy
  • Minerva Medica
    • Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Società Italiana per la Menopausa (SIM) and the Società Italiana della Terza Età (SIGiTE) [2019]
• Poland
  • Przeglad Menopauzalny = Menopause Review
    • Position statement by Experts of the Polish Menopause and Andropause Society, and the Polish Society of Aesthetic and Reconstructive Gynaecology on the medicinal product Intrarosa® [2019]
• Republic of Korea
  • Journal of Menopausal Medicine
    • Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements [2021]
• Spain
  • BMC Women's Health
    • Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study [2021]
  • Sexual Medicine
    • Impact of Vulvovaginal Atrophy of Menopause in Spanish Women: Prevalence and Symptoms According to the EVES Study [2019]
• United Kingdom
  • British Society for Sexual Medicine
    • Guidelines on the management of sexual problems in women: the role of androgens [2010]
  • National Institute for Health and Care Excellence
    • Transvaginal laser therapy for urogenital atrophy [2021]
  • Royal College of Obstetricians and Gynaecologists
    • Laser treatment for genitourinary syndrome of menopause [2022]
• United States
  • American College of Obstetricians and Gynecologists
    • Fractional Laser Treatment of Vulvovaginal Atrophy and U.S. Food and Drug Administration Clearance [2018]
  • Drugs & Aging
    • Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause [2019]
  • Endocrine Society
    • Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline [2014]
  • International Journal of Impotence Research
    • The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review [2022]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy
    • Female sexual disorders

Menopause, hormone replacement therapy: hot flashes, vasomotor symptoms

• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Anesthetic Injections Into the Stellate Ganglion for the Treatment of Hot Flashes in Women: A Review of Clinical and Cost-Effectiveness and Guidelines [2014]
  • Society of Obstetricians and Gynaecologists of Canada
    • Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle [2021]
    • Managing Menopause Chapter 4 Vasomotor Symptoms [2014]
• East Asia
  • Menopause
    • Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause [2022]
• Europe
  • International Journal of Women's Health
    • Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom [2013]
  • Maturitas
    • Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey [2023]
• Lebanon
  • International Journal of Reproductive Biomedicine
    • Prevalence of menopausal hot flashes in Lebanon: A cross-sectional study [2021]
• United States
  • National Cancer Institute
    • Hot Flashes and Night Sweats (PDQ®)
  • Obstetrics & Gynecology
    • Management of Menopausal Symptoms [2015]
  • Obstetrics & Gynecology Clinics of North America
    • Vasomotor Symptoms and Menopause: Findings from the Study of Women’s Health Across the Nation [2011]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy

Menopause: alternative therapy

• Australia
  • Australian Family Physician
    • What works? Evidence for lifestyle and nonprescription therapies in menopause [2011]
• Canada
  • Society of Obstetricians and Gynaecologists of Canada
    • Managing Menopause Chapter 9 Complementary and Alternative Medicine (CAM) [2014]
• Canada, United States
  • North American Menopause Society
    • Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society [2015]
• Europe
  • European Menopause and Andropause Society
    • EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms [2015]
• International
  • Journal of Family Medicine and Primary Care
    • Investigation of the role of herbal medicine, acupressure, and acupuncture in the menopausal symptoms: An evidence-based systematic review study [2020]
  • PLoS ONE
    • Chinese herbal formulae for the treatment of menopausal hot flushes: A systematic review and meta-analysis [2019]
• Republic of Korea
  • Complementary Therapies in Clinical Practice
    • Herbal prescription for managing menopausal disorders: A practice survey in Korean medicine doctors [2020]
• United Kingdom
  • British Journal of General Practice
    • Socioeconomic status and HRT prescribing: a study of practice-level data in England [2020]
• United States
  • Menopause
    • A Pooled Analysis of Three Studies of Non-Pharmacological Interventions for Menopausal Hot Flashes [2019]
    • Topical, Geospatial, and Temporal Diffusion of the 2015 North American Menopause Society Position Statement on Non-hormonal Management of Vasomotor Symptoms [2017]
  • U.S. Department of Veterans Affairs
    • Nonpharmacologic Treatments for Menopause-Associated Vasomotor Symptoms [2016]
• {Related topics}
  • Guidelines
    • Menopause, hormone replacement therapy